The first of a three-part investigative series by STAT News reveals a critical issue in health equity: the embedded bias in clinical algorithms. To address potential future inequities, a team from Boston Children’s embarked on a research journey to examine clinical algorithms and develop a more inclusive framework for evaluation and care. Learn more about this ongoing work from Dr. Alexandra Epee-Bounya and Dr. Bobby Rosen. http://ms.spr.ly/6046mDayj
Boston Children's Hospital
Hospitals and Health Care
Boston, MA 155,865 followers
Where the world comes for answers.
About us
Boston Children's Hospital is a 404-bed comprehensive center for pediatric health care. As one of the largest pediatric medical centers in the United States, Boston Children's offers a complete range of health care services for children from birth through 21 years of age. (Our services can begin interventions at 15 weeks gestation and in some situations we also treat adults.) We have approximately 25,000 inpatient admissions each year and our 200+ specialized clinical programs schedule 557,000 visits annually. Last year, the hospital performed more than 26,500 surgical procedures and 214,000 radiological examinations. Our team of physicians and nurses has been recognized by a number of independent organizations for overall excellence, and we're proud to share some notable examples with you here.
- Website
-
http://www.childrenshospital.org
External link for Boston Children's Hospital
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Boston, MA
- Type
- Nonprofit
- Founded
- 1869
- Specialties
- Research, Patient Services, Technology, Pediatrics, Hospital, and Innovation
Locations
Employees at Boston Children's Hospital
-
Andreas Ramos
Author of 22+ books on digital marketing | Adjunct Professor | Teach university-level AI-powered digital marketing at Omnes, CSTU, DMAnc | Graduate,…
-
Chris Newell
Senior Director Organizational Development at Boston Children's Hospital
-
Walter Pressey
Independent Director, Forsyth Institute
-
Michael Edson
IT Manager, Virtual Care and DH Emerging Tech
Updates
-
Fentanyl-related deaths have spiked over the past decade, many of them in people with no history of opioid use who used drugs laced with tiny amounts of fentanyl. What if we could protect people at risk with a vaccine, like the one being developed by the Precision Vaccines Program that would block fentanyl’s entry into the brain? Would people accept it? Elissa Weitzman, director of research in our Division of Addiction Medicine, posed these questions to a range of interviewees. Their answers were informative and sometimes surprising. 👇
Will people accept a fentanyl vaccine? - Boston Children's Answers
-
🗓️ On September 21, join us for the fifth annual “Cardiac Fitness Symposium for Congenital Heart Disease: The Power of Mindset Training.” This hybrid event (in-person and virtual options) will explore the science, practice, and execution of mindset training and behavior change for cardiac fitness programs. To learn more and register for the event, please visit ➡️ http://ms.spr.ly/6045m8zj9
-
-
We’re excited to unveil our newly renovated Neuroscience Inpatient Unit! 🎉 This cutting-edge space, strategically co-located with our Medical Surgical Intensive Care Unit, features 30 private patient rooms and an expanded Epilepsy Monitoring Unit. The design was crafted to foster enhanced collaboration within our Neurocritical Care Program and reinforces our commitment to advancing pediatric neurological care. 👏
-
-
MIS-C, the multisystem inflammatory disorder in children that emerged during the COVID-19 pandemic, posed a mystery: What caused it? The latest research from the national Overcoming COVID-19 Study, launched by Boston Children’s with funding from the CDC, shows it was a case of “molecular mimicry”: Some children’s immune systems reacted to a protein in their heart, lungs, kidneys, brain, skin, eyes, and GI tract as if it were a very similar COVID-19 protein, leading to a severe autoimmune reaction and an attack on children’s own tissues. 👇
Molecular mimicry in multisystem inflammatory syndrome in children - Nature
nature.com
-
In 2021, Ryan Flynn and colleagues in the lab of Carolyn Bertozzi showed that RNA, traditionally thought to be confined within cells, can appear on the cell surface in the form of glycoRNA, as can glycoproteins and glycolipids: http://ms.spr.ly/6048lfPNM The surprising discovery of glycoRNAs, which has implications for immunology, generated some scientific skepticism. But Flynn’s group now provides conclusive evidence of glycoRNAs’ existence, as detailed by HSCRB at Harvard University 👇
Unveiling GlycoRNA: New Study Proves They Do Exist | HSCRB
https://hscrb.harvard.edu
-
Olumide F. has always sought community — from arriving in the U.S. at age 15 to community college to his work today as a PhD student in the neuroscience lab of Beth Stevens. A strong sense of curiosity, instilled by his parents in Nigeria, has drawn him to study glial cells, multi-functional cells that intermingle with the brain’s neurons. He’s eager to mentor young scientists, especially those from nontraditional backgrounds, and has found other communities among fellow indoor rock climbers and blind wine tasters in his spare time. 👏👇
Olúmídé Fagboyegun: A neuroscience rising star - Boston Children's Answers
https://answers.childrenshospital.org
-
Proton-pump inhibitors (PPIs) are frequently prescribed to treat reflux in children, despite growing evidence of their risks. Recent research by Jason Zhang, MD, PhD, and Suzanna Hirsch, MD, in our Aerodigestive Center finds that PPIs don’t appear to increase COVID-19 risk in kids — but may alter the gut microbiome. Read more 👇
New insight into the effects of PPIs in children - Boston Children's Answers
https://answers.childrenshospital.org
-
Existing cancer immunotherapies don’t work for most solid tumors. Knowing that tumors can edit their genes to evade immune control, Judy Lieberman and colleagues in our Program in Cellular and Molecular Medicine took the first-ever comprehensive look at which genes are being edited. They then found a way to override the edits, restoring immune control over the tumor in a mouse model of breast cancer. This foundational work offers a roadmap for designing better immunotherapies. 👇
Anti-cancer strategy overrides tumor edits - Boston Children's Answers
https://answers.childrenshospital.org